At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MDGL Madrigal Pharmaceuticals
Trading 01-29 14:11:57 EST
493.81
-2.73
-0.55%
High500.15Low485.96Vol126.65K
Open497.38D1 Closing496.54Amplitude2.86%
Mkt Cap11.22BTradable Cap5.43BTotal Shares22.71M
T/O62.69MT/O Rate1.15%Tradable Shares11.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Rezdiffra Sales Milestone and Pfizer DGAT-2 Deal Might Change The Case For Investing In Madrigal Pharmaceuticals (MDGL)
Simply Wall St.  ·  01-29 07:38
Rezdiffra Sales Milestone and Pfizer DGAT-2 Deal Might Change The Case For Investing In Madrigal Pharmaceuticals (MDGL)
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug
Reuters  ·  01-28 23:36
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug
Madrigal Pharmaceuticals Initiated at Overweight by Barclays
Dow Jones  ·  01-28 22:52
Madrigal Pharmaceuticals Initiated at Overweight by Barclays
Madrigal Pharmaceuticals initiated with an Overweight at Barclays
TIPRANKS  ·  01-28 05:31
Madrigal Pharmaceuticals initiated with an Overweight at Barclays
Madrigal Pharmaceuticals Lobbying And Insider Sales Put Valuation In Focus
Simply Wall St.  ·  01-27 19:31
Madrigal Pharmaceuticals Lobbying And Insider Sales Put Valuation In Focus
Can Trump and Big Pharma Get the World to Pay More for Drugs? -- Heard on the Street -- WSJ
Dow Jones  ·  01-25
Can Trump and Big Pharma Get the World to Pay More for Drugs? -- Heard on the Street -- WSJ
BRIEF-Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Reuters  ·  01-23
BRIEF-Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer License For Ervogastat In MASH Therapy Combinations
Simply Wall St.  ·  01-23
Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer License For Ervogastat In MASH Therapy Combinations
Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire  ·  01-22
Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)
U.S. RESEARCH ROUNDUP-Datadog, IBM, Netflix
Reuters  ·  01-21
U.S. RESEARCH ROUNDUP-Datadog, IBM, Netflix
Top Madrigal Pharmaceuticals Insiders Quietly Cash In On Shares
TIPRANKS  ·  01-21
Top Madrigal Pharmaceuticals Insiders Quietly Cash In On Shares
Madrigal Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Rita Thakkar
Reuters  ·  01-21
Madrigal Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Rita Thakkar
Madrigal Pharmaceuticals Is Maintained at Market Outperform by Citizens
Dow Jones  ·  01-20
Madrigal Pharmaceuticals Is Maintained at Market Outperform by Citizens
Madrigal Pharmaceuticals price target raised to $745 from $527 at Citizens
TIPRANKS  ·  01-20
Madrigal Pharmaceuticals price target raised to $745 from $527 at Citizens
Assessing Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer Partnership In Metabolic Liver Disease
Simply Wall St.  ·  01-16
Assessing Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer Partnership In Metabolic Liver Disease
Director Paul A. Friedman Reports Disposal of Madrigal Pharmaceuticals Inc. Common Shares
Reuters  ·  01-14
Director Paul A. Friedman Reports Disposal of Madrigal Pharmaceuticals Inc. Common Shares
Director Rebecca Taub Reports Disposal of Madrigal Pharmaceuticals Inc. Common Shares
Reuters  ·  01-14
Director Rebecca Taub Reports Disposal of Madrigal Pharmaceuticals Inc. Common Shares
U.S. RESEARCH ROUNDUP-American Express, Ameriprise Financial, Mastercard
Reuters  ·  01-12
U.S. RESEARCH ROUNDUP-American Express, Ameriprise Financial, Mastercard
Madrigal Pharmaceuticals Inc : TD Cowen Raises Target Price to $644 From $554
THOMSON REUTERS  ·  01-12
Madrigal Pharmaceuticals Inc : TD Cowen Raises Target Price to $644 From $554
Roblox, First Solar, And League Enterprise Are Among Top 10 Large Cap Losers Last Week (Jan. 5-Jan. 9): Are the Others in Your Portfolio?
Benzinga_recent_news  ·  01-12
Roblox, First Solar, And League Enterprise Are Among Top 10 Large Cap Losers Last Week (Jan. 5-Jan. 9): Are the Others in Your Portfolio?

Introduction

Company Name.
Madrigal Pharmaceuticals
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor beta agonist, which is in Phase III clinical trials for treating NASH. The company is also developing MGL-3745, a backup compound to resmetirom. The company is headquartered in West Conshohocken, Pennsylvania.
Issue price:
--